A family of high-affinity, G protein-coupled receptors for the pineal hormone melatonin has been cloned from vertebrates. These recombinant receptors exhibit similar affinity and pharmacological characteristics to each other and to endogenous receptors, as defined with the melatonin agonist 2-[ 125 I]iodomelatonin ( 125 I-Mel). Two mammalian melatonin receptor subtypes have been identified by molecular cloning studies. The mammalian Mel 1a melatonin receptor is expressed in most sites containing 125 I-Mel binding. This includes the hypothalamic suprachiasmatic nucleus and hypophyseal pars tuberalis, presumed sites of the circadian and some of the reproductive actions of melatonin, respectively. The mammalian Mel 1b melatonin receptor is expressed in retina and brain and may mediate the reported effects of melatonin on retinal physiology in some mammals. A third receptor subtype, the Mel 1c melatonin receptor, has been cloned from zebra fish, Xenopus, and chickens but not from mammals. Molecular cloning of a melatonin receptor family now makes possible gene targeting to precisely determine the physiological role(s) of each receptor subtype.
Using the potent melatonin agonist 2-['25I]iodomelatonin (125I-Mel), high-affinity melatonin receptors have been identified in many vertebrate species (Reppert and Weaver, 1995; Reppert et al., 1996b; Dubocovich, 1995) . These receptors have an equilibrium dissociation constant (Kd) of less than 200 pM and exhibit pharmacological specificity (rank order of inhibition of specific 125 I-Mel binding is 2-iodomelatonin > melatonin ? 6-chloromelatonin > 6-hydroxymelatonin > N-acetyl-5-hydroxytryptamine » 5-hydroxytryptamine). Moreover, receptor affinity is sensitive to guanine nucleotides, and activation of these receptors consistently leads to inhibition of adenylyl cyclase through a pertussis toxin-sensitive mechanism. High-affinity melatonin receptors thus appear to belong to the superfamily of guanine nucleotide binding protein (G protein)-coupled receptors.
In vitro autoradiography has localized high-affinity melatonin receptors within individual brain nuclei and in a few nonneural sites. These receptor sites appear to be the sites through which melatonin elicits its biological effects (Reppert and Weaver, 1995; Reppert et al.,1996b; Dubocovich,1995) . Within mammalian brain, the distribution of melatonin receptors is restricted and species specific. In most mammals, including humans, high-affinity melatonin receptors are found in the suprachiasmatic nucleus (SCN) (Reppert et al., 1988; Dubocovich et al., 1996) ; SCN receptors probably mediate the circadian effects of melatonin. Receptors in the mediobasal hypothalamus of several photoperiodic rodents appear to be involved in melatonin's control of reproduction (Maywood and Hastings, 1995) . Receptors in the outer plexiform layer of the retina may mediate melatonin's effects on retinal physiology (Blazynski and Dubocovich, 1991) . Nonneural sites containing high-affinity melatonin receptors include the hypophyseal pars tuberalis (PT), a site involved in the photoperiodic regulation of prolactin and perhaps in other photoperiodic responses (Lincoln and Clarke, 1994) . High-affinity melatonin receptors also have been identified in cerebral and caudal arteries, which may be involved in thermoregulatory function in rodents (Viswanathan et al., 1990) .
A recent advance in understanding melatonin's actions has been the molecular cloning of a family of G protein-coupled receptors for melatonin (Reppert and Weaver, 1995; Reppert et al., 1996b) . The first high-affinity melatonin receptor was cloned using a cDNA library constructed from an immortalized cell line of Xenopus dermal melanophores and a mammalian cell expression cloning strategy . Structurally, the Xenopus receptor and related subtypes define a distinct receptor family within the large superfamily of G protein-coupled receptors ( Table 1) .
The melatonin receptor proteins are not similar in identity to any one particular group of G protein-coupled receptors but are similar to a wide range of receptors within the G protein-coupled receptor superfamily (amino acid identity approximately 25%). Distinguishing features of the melatonin receptor group include an NRY (rather than a DRY or an ERY) motif just downstream from the third transmembrane domain, a C(C/Y)ICHS motif immediately downstream from NRY, and an NAXXY (rather than an NPXXY) motif in transmembrane domain 7 (Fig. 1 ).
Using a polymerase chain reaction (PCR) approach based on the frog sequence, a high-affinity melatonin receptor that was 60% identical with the frog receptor at the amino acid level subsequently was cloned from several mammals, including humans . The mammalian receptors show more than 80% amino acid identity with each other and thus appear to be orthologs of the same receptor, designated the Mella melatonin receptor. The expressed recombinant mammalian receptors exhibit pharmacological and functional characteristics (coupled to Gi) that are similar to their endogenous counterparts (Table 1) . The Meha receptor gene is expressed in the rodent SCN and PT Roca et al., 1996) , prominent sites of 125I-Mel binding and the presumed sites of the circadian and some of the reproductive actions of melatonin, respectively. The Mella melatonin receptor may account for all the 125I-Mel binding observed by in vitro autoradiography in mammals. However, extremely low levels of receptor mRNA expression have prevented a firm determination as to whether the Mella receptor is responsible for 125I-Mel binding in some sites such as blood vessels.
A second receptor subtype, designated the Mehb receptor, was cloned from humans (Table 1) (Reppert et al., 1995a) . The human Mellb receptor is 60% identical to the human Mella receptor at the amino acid level.
The expressed Mehb receptor exhibits ligand binding characteristics that are very similar to those of the Mella receptor. The Mehb receptor also is coupled to Gi. Mehb receptor mRNA is not detectable by in situ hybridization in rat brain or pituitary, but reverse transcription PCR shows that the Mehb receptor transcript is expressed in human retina and brain. The Mehb receptor may mediate the reported actions of melatonin in the retina of some mammals. Curiously, the Mellb receptor is nonfunctional in Siberian, Djungarian, and Syrian hamsters Weaver and Reppert, unpublished data) , suggesting that in these species the Mella receptor (which is functional) single-handedly mediates the physiological effects of melatonin.
A Melle receptor subtype also exists. Molecular cloning studies in chickens have identified a high-affinity melatonin receptor that is 80% identical with the frog receptor at the amino acid level but only 60% identical with the Meha and Mehb receptors (Reppert et al., 1995b) . This subtype, designated the Melie receptor, has pharmacological and functional properties similar to the mammalian Mella and Mehb receptors (Table 1) . PCR analysis of additional melatonin receptor fragments from Xenopus and zebra fish provided further evidence of three distinct melatonin receptor subtypes in vertebrates (Fig. 2) (Reppert et al., 1995b) .
A Melle receptor ortholog has not yet been cloned in mammals. It is possible that mammals have evolved without a Melle receptor gene or that sequence diver- Figure 2 . Phylogenetic analysis of G protein-coupled melatonin receptors and melatonin-related receptors (H9). The regions comprising transmembrane segments 4-7 were used to calculate a-tree using the maximum parsimony method (Reppert et al., 1995b ).
The numbers above and below the branches are the results of bootstrap analysis and are related to a confidence limit for the positions of the branches. The rat p opioid receptor sequence provided an out-group for the tree. GeneBank accession numbers are U14109 (human Mella), U14108 (sheep Mella), U14110 (hamster Mella), U14409 (rat Melia), U31822 (zebra fish Zl.7), U31820 (chicken Mella), U31823 (zebra fish Zl.4), U31826 (Xenopus X2.0), U25341 (human Mehb), U31827 (Xenopus X1.7), U30609 (chicken Mehb), U31824 (zebra fish Z2.6), U52220 (zebra fish Z6.2), U09561 (Xenopus Melle)' U31821 (chicken Melle)' U31825 (zebra fish Z2.3), U52219 (human H9), U52221 (sheep H9), and U52218 (rat H9). gence is too great for detection by PCR and library screening. Further molecular cloning studies are needed to clarify this issue.
The three melatonin receptor subtypes have similar gene structure (Reppert et al., ,1995a (Reppert et al., , 1995b Roca et al., 1996) . The portion of the gene that encodes the receptor proteins is composed of 2 exons separated by a large (> 8 kb) intron. The two human melatonin receptor genes isolated reside on different chromosomes : Mella on 4q35.1 and Mehb on llq21-22 (Slaugenhaupt et al.,1995; Reppert et al., 1995a) . These loci are not linked to any known genetic diseases that might involve mutations of these receptors.
Recently, an orphan G protein-coupled receptor was cloned that is 45% identical to the human Mella and Mehb receptors at the amino acid level (Reppert et al., 1996a) . Structural analysis of the protein and its gene, along with phylogenetic analysis, further shows that the orphan receptor is closely related to the G protein-coupled melatonin receptor family (Fig. 2 ).
Unusual features of this &dquo;melatonin-related receptor&dquo; include the lack of N-linked glycosylation sites and a carboxyl tail more than 300 amino acids long. The orphan receptor does not bind 125I-Mel or [3H]melatonin. Melatonin-related receptor mRNA is expressed in hypothalamus and pituitary, suggesting that the receptor and its natural ligand are involved in neuroendocrine function.
Cloning a family of G protein-coupled melatonin receptors provides new tools for investigating fundamental mechanisms of melatonin action. For example, gene targeting can now be performed to determine the precise role of each receptor subtype in the circadian, retinal, and vascular responses to melatonin. Recombinant melatonin receptors also make possible the development of subtype-specific agonists and antagonists that may have therapeutic applications.
